Related Experiment Video
Updated: Jan 1, 2026

12:34
Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome
Published on: April 2, 2018
13.9K
Biochemical diagnosis in prolactinomas: some caveats
1ENDOC Center for Endocrine Tumors, Erik-Blumenfeld-Platz 27a, 22587, Hamburg, Germany. stephan.petersenn@endoc-med.de.
Pituitary
|December 25, 2019
Summary
Diagnosing hyperprolactinemia, often caused by prolactinomas, requires careful biochemical analysis. This review addresses analytical challenges and overlapping conditions that can complicate accurate prolactin level interpretation.
Area of Science:
- Endocrinology
- Clinical Chemistry
Background:
- Prolactinomas are the most common pituitary adenomas.
- Accurate diagnosis of hyperprolactinemia is crucial for patient management.
- Biochemical diagnosis can be challenging due to analytical issues and overlapping conditions.
Purpose of the Study:
- To review the diagnostic challenges in hyperprolactinemia.
- To discuss analytical difficulties and interfering factors in prolactin level measurement.
- To explore physiological and pathological causes of elevated prolactin.
Main Methods:
- Literature review of studies on hyperprolactinemia and prolactinomas.
- Analysis of potential causes for discrepant clinical and biochemical findings.
- Discussion of assay interferences, macroprolactinemia, and the hook effect.
Main Results:
- Analytical difficulties can lead to false positive or false negative prolactin levels.
- Macroprolactinemia and the high-dose hook effect are significant sources of error.
- Numerous physiological and pathological conditions can increase prolactin levels, mimicking prolactinomas.
Conclusions:
- Clinical suspicion is vital when symptoms and biochemical results are incongruent.
- Understanding analytical interferences and differential diagnoses is essential for correct hyperprolactinemia diagnosis.
- Proper interpretation of prolactin levels requires consideration of various interfering factors and conditions.
Keywords:
Chronic kidney diseaseHigh-dose hook effectHyperprolactinemiaHypothyroidismLiver diseaseMacroprolactinemiaPregnancy
